JAAD International (Sep 2022)

Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart review

  • Ronald Vender, MD,
  • Irina Turchin, MD,
  • Perla Lansang, MD,
  • Vimal H. Prajapati, MD,
  • Mark Legault, PhD,
  • Maxime Barakat, MD, PhD, MBA,
  • Jensen Yeung, MD

Journal volume & issue
Vol. 8
pp. 60 – 63

Abstract

Read online

No abstracts available.

Keywords